Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory Elliott

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Circulation|June 30, 2010
Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)Raymond L Benza, Dave P Miller, Mardi Gomberg-Maitland, et al.
Chest|November 26, 2016
EIF2AK4 Mutations in Patients Diagnosed With Pulmonary Arterial HypertensionD Hunter Best, Kelli L Sumner, Benjamin P Smith, et al.
Chest|June 18, 2014
Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel reportDarren B Taichman, Joe Ornelas, Lorinda Chung, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 15, 2015
Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome: Study Rationale and Design (ASTRO-APS)Scott C Woller, Scott M Stevens, David A Kaplan, et al.
Journal of the American College of Cardiology|June 27, 2009
Updated clinical classification of pulmonary hypertensionGérald Simonneau, Ivan M Robbins, Maurice Beghetti, et al.
The New England Journal of Medicine|August 28, 2018
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical IllnessAlex C Spyropoulos, Walter Ageno, Gregory W Albers, et al.
Pulmonary Circulation|September 10, 2013
Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertensionRajeev Malhotra, Samuel Paskin-Flerlage, Roham T Zamanian, et al.
Journal of the American College of Cardiology|June 27, 2020
Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill PatientsAlex C Spyropoulos, Walter Ageno, Gregory W Albers, et al.
Circulation|April 15, 2009
Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patientsGregory Piazza, Erin J Rosenbaum, William Pendergast, et al.
Pulmonary Circulation|May 18, 2019
United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implicationsC Gregory Elliott, Eric D Austin, David Badesch, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Circulation|June 30, 2010
Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)Raymond L Benza, Dave P Miller, Mardi Gomberg-Maitland, et al.
Chest|November 26, 2016
EIF2AK4 Mutations in Patients Diagnosed With Pulmonary Arterial HypertensionD Hunter Best, Kelli L Sumner, Benjamin P Smith, et al.
Chest|June 18, 2014
Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel reportDarren B Taichman, Joe Ornelas, Lorinda Chung, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 15, 2015
Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome: Study Rationale and Design (ASTRO-APS)Scott C Woller, Scott M Stevens, David A Kaplan, et al.
Journal of the American College of Cardiology|June 27, 2009
Updated clinical classification of pulmonary hypertensionGérald Simonneau, Ivan M Robbins, Maurice Beghetti, et al.
The New England Journal of Medicine|August 28, 2018
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical IllnessAlex C Spyropoulos, Walter Ageno, Gregory W Albers, et al.
Pulmonary Circulation|September 10, 2013
Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertensionRajeev Malhotra, Samuel Paskin-Flerlage, Roham T Zamanian, et al.
Journal of the American College of Cardiology|June 27, 2020
Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill PatientsAlex C Spyropoulos, Walter Ageno, Gregory W Albers, et al.
Circulation|April 15, 2009
Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patientsGregory Piazza, Erin J Rosenbaum, William Pendergast, et al.
Pulmonary Circulation|May 18, 2019
United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implicationsC Gregory Elliott, Eric D Austin, David Badesch, et al.
Pageof 12